News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
812,026 Results
Type
Article (75151)
Company Profile (693)
Press Release (736182)
Section
Business (230229)
Career Advice (3738)
Deals (39372)
Drug Delivery (116)
Drug Development (89687)
Employer Resources (194)
FDA (17812)
Job Trends (17114)
News (391175)
Policy (38887)
Tag
Academia (2974)
Alliances (56084)
Alzheimer's disease (1336)
Approvals (17719)
Artificial intelligence (156)
Bankruptcy (393)
Best Places to Work (12520)
Biotechnology (476)
Breast cancer (131)
Cancer (1175)
Cardiovascular disease (109)
Career advice (3183)
Cell therapy (266)
Clinical research (70850)
Collaboration (419)
Compensation (204)
COVID-19 (2803)
C-suite (106)
Data (1150)
Diabetes (168)
Diagnostics (6679)
Earnings (93960)
Employer resources (167)
Events (126238)
Executive appointments (328)
FDA (18377)
Funding (373)
Gene therapy (200)
GLP-1 (692)
Government (5004)
Healthcare (20705)
Infectious disease (2896)
Inflammatory bowel disease (121)
Interviews (730)
IPO (17546)
Job creations (5020)
Job search strategy (2613)
Layoffs (488)
Legal (9896)
Lung cancer (190)
Manufacturing (200)
Medical device (14403)
Medtech (14408)
Mergers & acquisitions (21873)
Metabolic disorders (471)
Neuroscience (1643)
NextGen Class of 2024 (7619)
Non-profit (5063)
Northern California (1517)
Obesity (270)
Opinion (244)
Patents (112)
People (63572)
Pharmaceutical (136)
Phase I (21869)
Phase II (30871)
Phase III (23251)
Pipeline (466)
Postmarket research (3329)
Preclinical (9700)
Radiopharmaceuticals (258)
Rare diseases (244)
Real estate (7202)
Regulatory (25414)
Research institute (2640)
Resumes & cover letters (585)
Southern California (1341)
Startups (4219)
United States (14556)
Vaccines (652)
Weight loss (220)
Date
Today (139)
Last 7 days (832)
Last 30 days (4031)
Last 365 days (38358)
2024 (35194)
2023 (42565)
2022 (53927)
2021 (58724)
2020 (57670)
2019 (51309)
2018 (39093)
2017 (36871)
2016 (37862)
2015 (43938)
2014 (38871)
2013 (35055)
2012 (37083)
2011 (37225)
2010 (36951)
Location
Africa (1190)
Arizona (228)
Asia (47899)
Australia (8246)
California (3529)
Canada (1306)
China (262)
Colorado (156)
Connecticut (170)
Europe (108451)
Florida (473)
Georgia (127)
Illinois (405)
Indiana (215)
Kansas (103)
Maryland (629)
Massachusetts (2854)
Michigan (177)
Minnesota (297)
New Jersey (1005)
New York (998)
North Carolina (838)
Northern California (1517)
Ohio (149)
Pennsylvania (867)
South America (1570)
Southern California (1341)
Texas (499)
Washington State (396)
812,026 Results for "ajinomoto co inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto Co., Inc. launched a new version of its StemFit™ iPSC expansion medium.
March 26, 2024
·
3 min read
Deals
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. and Forge Biologics, announced that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million.
November 13, 2023
·
4 min read
Ajinomoto Co. Launches Silicon Valley CVC HQ to Grow U.S. Investments, Adds New Portfolios
Ajinomoto Co., Inc., the Japan-based multinational corporation covering food, healthcare and electronic materials, and built on “AminoScience,” has expanded its corporate venture capital arm with new U.S. headquarters to grow its investments in U.S. and global companies.
February 13, 2024
·
2 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Biotech Beach
Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both the Overall and Big Pharma respondent groups.
March 12, 2024
·
2 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Career Advice
How to Deal With a Toxic Co-Worker
Dealing with a toxic co-worker can be exhausting, and it can make your workplace more stressful. There are a few ways to make it easier, including developing healthy coping mechanisms and even talking it out with your colleague.
September 25, 2024
·
5 min read
·
Alina Zahid
Press Releases
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
·
10 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
October 23, 2024
·
6 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
1 of 81,203
Next
